FDA Investigator Camerson E Moore

Camerson E Moore has conducted inspections on 162 sites in 13 countries as of 29 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
162
Last Inspection Date:
29 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100001819
Countries of Inspections:
United States of America, Italy, China, Taiwan, United Kingdom of Great Britain and Northern Ireland, Switzerland, Canada, Japan, India, Thailand, Singapore, Korea (Republic of), Poland
FDA Investigators that have inspected at least one site in common with Camerson E Moore:
Abby E Pelletier, Ademola O Daramola, Akbar J Zaidi, Alan R Condon, Alice C Silva, Althea A Williams, Alysia M Salonia, Amanda E Lewin, PhD, Amber G Wardwell, Amy C Jordan, Ana Mariaa Plapcianu, Andre S Lamontagne, Andrea A Branche, Andrew M Barlow, Angel Asoler Garcia, Anh M Lac, Anissa M Vargas, Anthony N Onianwa, Aqualia L Nelson, Arie C Menachem, Ashar P Parikh, Aurora Miha Trifanov, Barbara D Wright, Barry Rothman, Bijoy Panicker, Blondell W Johnson, Bogdan Kurtyka, Bonita S Chester, Bradley D Newsad, Brenda P King, Brenda W Uratani, PhD, Brian J Ryan, Brittny C Cargo, Brooke K Higgins, Carla C Tuite, Carla J Lundi, Caryn M Mcnab, Celia N Cruz, Charanjeet Jassal, Charisse K Green, Charles D Brown, Charles R Clavet, Christina Capacci Daniel, PhD, Christopher N Tran, Christopher T Middendorf, Claire M Minden, Clifton L Randell, Clinton J Lott, Cody D Rickman, Connie Lucero, Courtney N Long, Craig T Rybus, Damaris Y Hernandez, Daniel J Lahar, Daniell Gill, Jr, Darin S Wiegers, Darla J Christopher, Daryl A Dewoskin, David Acevedo, David H Smith, David J Feria, David M Beltran, David P Vanhouten, David S Firley, Dawn M Braswell, Dean R Rugnetta, Dellarese L Herbert, Demario L Walls, Denise Connelly, Denise M Digiulio, Diane C Thibodeau, Diane L Raccasi, Diane M Biron, Dipesh K Shah, Dolores Harper, Dominic R Frasca, Dr. Jason R Caballero, Edmund F Mrak, Jr, Eduardo L Rodriguez, Edward D Edmiston, Edward J Janik, Edwin Ramos, Eileen A Liu, Elizabeth B Griffin, Elizabeth D Connell, Elizabeth P Kinsella, Ellen J Kleintop, Ellen J Tave, Emilio O Escobar, Emily J Orban, Enspect User, Eric C Behrens, Eric C Schmitt, Ernest Serna, III, Felix Maldonado, Francis J Eng, Gam S Zamil, Gamal A Norton, Garry H Stewart, Gary J Hagan, George T Allen, Jr, Gerard J Desany, Gilbert Valdez, RS, Gregson A Joseph, Guerlain Ulysse, Habacuc V Barrera, Haijing Hu, Hala L Selby, Helen Verdel, Hung V Le, Inga M Warr, Iris C Macinnes, Israel Santiago, OCM, Ivis L Negron, J Elkins, James A Jagon, James C Maclaughlin, James H Tanner, James W Whitney, Janet B Abt, Janet L Bowen, Janice M Hickok, Jd Young, Jeffery A Hangartner, Jeffrey J Thibodeau, Jeffrey R Wooley, Jennifer T Szymanski, Jessica L Johnson, Jessica P Mcalister, Joanne E King, Jocelyn C Turner, Joel D Martinez, Joey V Quitania, Johann M Fitch, John A Gonzalez, John A Sciacchitano, John J Thibodeau, John P Mistler, John P Shelton, John R Carlson, John S Hartford, Jonathan B Lewis, Jonathan G Matrisciano, Jose A Lopez, Jose A Torres, Jose Acruz Gonzalez, Jose Martinez, Jr, Justin A Boyd, Justine M Corson, Kara A Scheibner, PhD, Karen M Cooper, Karen Mcnabb Noon, Kari M Johansen, Kari M Laynor, Karishma G Gopaul, Katherine Szestypalow, Kathleen E Mcafoose, Kayla V Sprague, Kenitra D Hewitt, Kenneth H Williams, Kevin P Foley, Kevin P Regan, Khunnathee Stoner, Kwong P Lee, L Grant, Lance D Johnson, Lane V Christensen, PhD, Larry K Austin, Latorie S Jones, Laureen M Geniusz, Lauren N Howard, Laurie B Frazier, LCDR Debra Emerson, Leighton Kn Gai, Li Hongpaul Yeh, PhD, Li Li, Libia M Lugo, Linda F Murphy, Lisa R Jennings, Lisa R Whitt, Logan T Williams, Lori G Cantin, Lori M Graham, Luis A Dasta, Luis A Salinas, Luis Mburgos Medero, Luis Salinas, Maotang Zhou, PhD, Marcia M Laughrey, Marcus A Ray, Margaret M Annes, Marie F Morin, Marijo B Kambere, PhD, Mark C Flotte, Mark E Parmon, Mark R Mcclain, Mary Jeanet Mcgarry, Maryam Tabatabaie, Massoud Motamed, Matthew B Casale, Matthew C Watson, Maura Rooney, Max Lager, Maya M Davis, Megan A Haggerty, Michael G Mayfield, Michael G Townsand, Michael J Pasternak, Michael P Sweeney, Michael R Goga, Nabil Nakhoul, Nicholas A Violand, Nicholas F Lyons, Nicholas Z Lu, Nicole E Knowlton, Noreen Muñiz, Pamela L Ogonowski, Paraluman S Leonin, Parul M Patel, Patrice S Hall, Patricia M Jacobs, Patrick C Klotzbuecher, Patrick D Stone, MS, Patty P Kaewussdangkul, Paul A Bonneau, Paul P Geraci, Paula J Perry, Peter C Chow, Philip H Lafleur, Rafael Nevarez Nieves, Ramon E Martinez, Reba A Gates, Richard F Hapke, Richard H Penta, Robert J Martin, Robert O'brian, Roger F Zabinski, Rose Ashley, Roy Baby, Roy R Rinc, Rupa Pradhan, Russell K Riley, Samina S Khan, Samuel J Arsenault, Sandra P White, Sandy J Ziegler, Santos E Camara, Sara M Onyango, Sara Rothman, Saundrea A Munroe, Scott T Ballard, Sean R Marcsisin, Seth A Mailhot, Sha'tina R Alridge, Shanna N Purdy, Sharmista Chatterjee, Sharon K Thoma, PharmD, Shawn M Bogdan, Shelby N Turner, Shirley S Wen, Simone E Pitts, Sneha S Patel, Sonia R Peterson, Stacey S Degarmo, Stacie A Woods, Stephen C Smith, Stephen D Brown, Stephen L Beekman, Steven A Brettler, Steven M Ferrara, Steven M Weinman, Sunita Pandey, Susan F Laska, MS, Susan O Oladeji, Susanne M Richardson, MS RAC, Suyang Qin, Suzanne M Healy, Suzanne N Vallez, Tamara S Rosbury, Tania K Mercado, Temar Q Williams, Terry C Kimball, Theresa Kirkham (NMI), Thomas J Arista, Thomas W Nojek, Timothy H Vo, Torrance J Slayton, Travis S Brown, Tricia S Martinez, Tricia Y Samaniego, Truong Xuan Nguyen (Andy), Unnee Ranjan, Uttaniti Limchumroon (Tom), Victor J Gangi, Vioela J Caze, Vitaliy N Guyvan, Vivian Garcia, Vivin George, Walden H Lee, Wayne E Seifert, William K Dagley, William S Boivin, Xiaojun Yan, Xiaokuang Lai, PhD, Xiaoping Guan, Xikui Chen (nmi), PhD, Yehualashet A Gessesse, Yiying E Chen, Yong Hu, Youmin Wang, Yvette S Montes, Zachary L Miller, Zhigang Sun, PhD, Zhongren Wu

Camerson E Moore's Documents

Publish Date Document Type Title
May, 2013 FDA 483 Haemonetics Corporation - Form 483, 2013-05-03
February, 2013 FDA 483 Optim LLC - Form 483, 2013-02-07
June, 2015 FDA 483 Hubei Weikang Protective Products Co., Ltd. - Form 483, 2015-06-04
November, 2011 FDA 483 ZOLL Medical Corporation - Form 483, 2011-11-17
August, 2016 FDA 483 DPT Laboratories, Ltd. - Form 483, 2016-08-26
September, 2022 FDA 483 Apotex Inc. - Form 483, 2022-09-14
July, 2012 FDA 483 Myomo Inc - Form 483, 2012-07-31
October, 2021 FDA 483 Vita Pharmacy, LLC dba Talon Compounding Pharmacy - Form 483, 2021-10-06
December, 2018 EIR Nexgen Pharma, Inc. - EIR, 2019-02-05
June, 2022 EIR QuVa Pharma, Inc. - EIR, 2022-06-16
June, 2016 FDA 483 Struckmyer Medical - Form 483, 2016-06-09
August, 2018 FDA 483 Vita Pharmacy, LLC dba Talon Compounding Pharmacy - Form 483, 2018-08-03
February, 2022 FDA 483 University of Texas MD Anderson Cancer Center - Form 483, 2022-02-16
September, 2013 FDA 483 R.H. Kaplan Associates, Inc. d/b/a David Scott Company - Form 483, 2013-09-13
September, 2019 FDA 483 Olon SpA - Form 483, 2019-09-13
August, 2022 FDA 483 QuVa Pharma, Inc. - Form 483, 2022-08-18
April, 2015 FDA 483 Custom Compounding Center - Form 483, 2015-04-09
January, 2015 FDA 483 University of Texas MD Anderson Cancer Center - Form 483, 2015-01-16
April, 2014 FDA 483 PLZ Corp - Form 483, 2014-06-04
May, 2022 FDA 483 Revive Rx LLC dba Revive Rx Pharmacy - Form 483, 2022-05-04
August, 2021 FDA 483 Prescription Labs Inc dba Greenpark - Form 483, 2021-08-12
June, 2018 FDA 483 Agno Pharma Jiangsu - Form 483, 2018-06-21
April, 2019 FDA 483 QuVa Pharma, Inc. - Form 483, 2019-04-23
July, 2015 FDA 483 Portable Therapeutix - Form 483, 2015-07-22
January, 2020 FDA 483 Brio Pharmaceuticals, Inc. - Form 483, 2020-01-24
January, 2011 FDA 483 Nova Biomedical Corporation - Form 483, 2011-01-13
December, 2012 FDA 483 Arteriocyte Medical Systems Inc - Form 483, 2012-12-11
May, 2013 FDA 483 Cogmedix, Inc. - Form 483, 2013-05-31
March, 2017 FDA 483 Ultrasonic Services, Inc. - Form 483, 2017-03-10
January, 2020 EIR Brio Pharmaceuticals, Inc. - EIR, 2020-01-24
February, 2014 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2014-02-20
February, 2015 FDA 483 FOCUS Laboratories, Inc. - Form 483, 2015-02-06
June, 2022 FDA 483 QuVa Pharma, Inc. - Form 483, 2022-06-16
February, 2015 EIR FOCUS Laboratories, Inc. - EIR, 2015-02-06
September, 2017 FDA 483 Evonik Active Oxygens, LLC - Form 483, 2017-09-06
September, 2017 EIR Evonik Active Oxygens, LLC - EIR, 2017-09-06
September, 2019 FDA 483 ANCOROTTI COSMETICS SPA - Form 483, 2019-09-19
October, 2011 FDA 483 iWalk Inc. D.B.A. Biom - Form 483, 2011-10-13
March, 2020 FDA 483 Empower Clinic Services LLC dba Empower Pharmacy - Form 483, 2020-03-06
April, 2012 FDA 483 Z-Medica, LLC. (fully owned subsidiary Teleflex) - Form 483, 2012-04-18
March, 2023 FDA 483 Prisma Health Outsourcing Facility - Form 483, 2023-03-03
January, 2014 FDA 483 Lyophilization Services Of New England, Inc. (LSNE) - Form 483, 2014-01-29
May, 2015 FDA 483 Advanced Micro Vas II, LLC - Form 483, 2015-05-08
April, 2019 FDA 483 Response QuVa Pharma, Inc. - Form 483R, 2019-05-14
June, 2021 FDA 483 Front Door Pharmacy, LLC dba Pure Pharmacy (Pure Pharmaceuticals) - Form 483, 2021-06-07
January, 2013 FDA 483 Terumo Cardiovascular Systems Corp - Form 483, 2013-01-17
September, 2015 FDA 483 PharMedium Services, Llc - Form 483, 2015-09-24
September, 2023 FDA 483 Strive Pharmacy Texas LLC dba Strive Pharmacy - Form 483, 2023-09-08
March, 2019 FDA 483 Front Door Pharmacy, LLC dba Pure Pharmacy (Pure Pharmaceuticals) - Form 483, 2019-03-18
April, 2018 FDA 483 Olympia Compounding Pharmacy - Form 483, 2018-04-13
November, 2019 FDA 483 Abilene Nuclear LLC dba National Central Pharmacy - Form 483, 2019-11-07
November, 2012 FDA 483 Arthrosurface, Inc. - Form 483, 2012-11-09
June, 2010 FDA 483 Cardea Technology, Inc - Form 483, 2010-06-21
April, 2023 FDA 483 Professional Compounding Centers of America dba PCCA - Form 483, 2023-04-21
December, 2023 FDA 483 EMPOWER CLINIC SERVICES LLC - Form 483, 2023-12-01
August, 2019 FDA 483 Randol Mill Pharmacy - Form 483, 2019-08-06
July, 2019 EIR Brio Pharmaceuticals, Inc. - EIR, 2019-07-11
December, 2019 FDA 483 Eagle Analytical Services, Ltd. - Form 483, 2019-12-17
October, 2012 FDA 483 Keystone Dental Inc - Form 483, 2012-10-12
June, 2022 FDA 483 Response QuVa Pharma, Inc. - Form 483R, 2022-07-08
May, 2019 FDA 483 IsoTherapeutics Group LLC - Form 483, 2019-05-17
March, 2018 FDA 483 Cantrell Drug Company - Form 483, 2018-03-22
March, 2022 EIR RadioMedix, Inc. - EIR, 2022-03-24
August, 2016 EIR DPT Laboratories, Ltd. - EIR, 2016-08-29
November, 2018 FDA 483 The Methodist Hospital - Form 483, 2018-11-02
April, 2011 FDA 483 Cardea Technology, Inc - Form 483, 2011-04-29
March, 2022 FDA 483 RadioMedix, Inc. - Form 483, 2022-03-24
January, 2019 FDA 483 GUILIN CHINA RESOURCES TIANHE PHARMACEUTICAL CO LTD - Form 483, 2019-01-11
February, 2023 FDA 483 Iso-Tex Diagnostics, Inc. - Form 483, 2023-02-10
January, 2016 FDA 483 Whitehill Manufacturing Inc - Form 483, 2016-01-20
December, 2022 FDA 483 Wells Pharma of Houston LLC - Form 483, 2022-12-14
July, 2019 FDA 483 Brio Pharmaceuticals, Inc. - Form 483, 2019-07-11
October, 2014 FDA 483 New England Home Therapies, Inc - Form 483, 2014-10-08
October, 2014 FDA 483 Vertex Pharmaceuticals Incorporated - Form 483, 2014-10-16
October, 2018 FDA 483 OCuSOFT INC. - Form 483, 2018-10-17
September, 2022 FDA 483 LEC Custom Products, Inc - Form 483, 2022-09-02
March, 2016 FDA 483 Wenzel Spine - Form 483, 2016-03-11
August, 2011 FDA 483 Smith & Nephew, Inc. - Form 483, 2011-08-15

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more